Halozyme Therapeutics | HALO - الأصول





الأصول تغيير تاريخ
Acadia Pharmaceuticals USD 1.74B 137.67M 2026-06
Agios Pharmaceuticals USD 1.11B 76.57M 2026-06
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
Amarin USD 624.36M 21.4M 2026-06
Amgen USD 95.64B 3.14B 2026-06
Baxter International USD 19.79B 55M 2026-06
Cara Therapeutics USD 25.82M 6.26M 2026-03
Cytokinetics USD 1.92B 651.07M 2026-06
DBV Technologies USD 223.2M 43.2M 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Halozyme Therapeutics USD 2.58B 95.31M 2026-06
Intrexon USD 73.16M 77.88M 2024-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
MannKind USD 732.3M 12.1M 2026-06
Minerva Neurosciences USD 97.97M 69.88M 2025-12
Nektar Therapeutics USD 763.27M 482.86M 2026-03
Pfizer USD 201.13B 6.49B 2026-06
Rigel Pharmaceuticals USD 242.53M 35.8M 2025-09
United Therapeutics USD 7.22B 505.9M 2026-06
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12